Hikma Pharmaceuticals PLC (LSE:HIK) - Share price - Overview

Stock Report

Hikma Pharmaceuticals PLC HIK

Last Price
GBX1,943.00

Day Change
38.00|1.99%

As of 26/04/2017
17:07:30 BST | GBX
Minimum 15 Minutes Delay.

Last Close1,905.00p
Day Range1,900.00 - 1,946.00
Mkt Cap4.66Bil
52-Wk Range1,575.00 - 2,703.00
Yield %1.18
ISINGB00B0LCW083
Volume797,603
P/E30.70
P/S3.13
P/CF25.36

Share Price

Total Returns -

 Chg (%)  
More ...
Hikma Pharmaceuticals PLC- 
 
Financials
201420152016
More ...
Income Statement
Turnover906.03942.521,444.56
Operating Profit244.61249.38223.72
Net Profit171.59166.25117.05
Reported EPS84.5882.0849.04
Balance Sheet
Current Assets650.84922.721,171.85
Non Current Assets795.39839.272,359.08
Total Assets1,446.231,761.993,530.93
Current Liabilities540.33401.66742.93
Total Liabilities664.97844.701,579.73
Total Equity781.26917.291,951.20
Cash Flow
Operating Cash Flow306.67272.94273.36
Net Change in Cash68.76183.92-283.73
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2017351.85108.5771.5517.900.2527.331.41
2018390.81121.6712.0715.971.3232.071.65

Regulatory News

Director Dealings
TradedActionNotifierPriceAmountValue
More ...
24/04/2017PurchaseNina Henderson1,866.833,50065,339.00
19/12/2016Transfer OutMr. Mazen Darwazah0.005,449,7160.00
19/12/2016PurchaseMr. Mazen Darwazah1,790.0050,000895,000.00
19/12/2016PurchaseMohammed Ali Al-Husry1,790.0050,000895,000.00

Company Profile

Hikma Pharmaceuticals PLC develops, manufactures and markets a broad range of branded and non-branded generic pharmaceutical products across the US, the MENA region, and Europe.

Sector

Drug Manufacturers - Specialty & Generic

Market Position

102 of 1850 Companies

Index

FTSE 100 ,FTSE 350 ,FTSE All Share

Outlook

(07/04/2017) no outlook statement

Next Event 19/05/2017

Next AGM
Ratios
CompSecMkt
More ...
PER (E)17.2414.0516.23
Div Yld (E)1.483.834.19
PEG (E)0.380.341.00
ROCE17.70180.4518.51
Op Mrgn15.44-5.77-0.44
EPS Grwth45.3269.3727.38
Dividends
PreviousLatest
More ...
Record Date02/09/1607/04/17
Ex-Div01/09/1606/04/17
Paid30/09/1625/05/17
Amnt8.4517.91

Broker Sentiment

Strong Buy0
Buy3
Hold1
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
Chairman & Chief Executive OfficerMr. Said Darwazah
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.